Unusual presentations of neurocysticercosis

Acta Neurologica Scandinavica

Volumn 115, Issue 3, 2007, Pages 192-198

  Hamed, S A ^a   El Metaal, H E ^a  

^a Saudi German Hospital   (Saudi Arabia)

Author keywords

Dystonia; Endemic areas; Neurocysticercosis; Parietal lobe syndrome

Indexed keywords

CARBAMAZEPINE; CARBIMAZOLE; DEXAMETHASONE; PRAZIQUANTEL; SPASMOLYTIC AGENT; STEROID; TIAPRIDE;

ADOLESCENT; ADULT; APRAXIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; COORDINATION DISORDER; DEPRESSION; DRUG DOSE REDUCTION; DYSTONIA; FEMALE; GOITER; HUMAN; LETHARGY; MENTAL DEFICIENCY; MICTURITION DISORDER; NEUROCYSTICERCOSIS; PSEUDOBULBAR PALSY; SENSORY DYSFUNCTION; SPASTICITY; WEIGHT GAIN;

ADOLESCENT; ADULT; BRAIN DISEASES; FEMALE; HUMANS; NEUROCYSTICERCOSIS; SAUDI ARABIA;

EID: 33846880241     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00747.x     Document Type: Article

References (27)

1. SINGHI P, SINGHI S. Neurocysticercosis in children. J Child Neurol 2004;19:482-92.
2. DEL BRUTTO OH. Neurocysticercosis. Semin Neurol 2005;25:243-51.
3. SHANDERA WX, WHITE C, CHEN JC et al. Neurocysticercosis in Houston, TX: a report of 112 cases. Medicine 1994;73:37-52.
4. ONG S, TALAN DA, MORAN GJ et al. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 2002;8:608-13.
5. DEL BRUTTO OH, SOTELO J, ROMÁN GC. Neurocysticercosis: a clinical handbook. Lisse, The Netherlands: Swets and Zeitlinger, 1998.
6. SAWHNEY BB, CHOPRA JS, BANERJI AK, WAHI PL. Pseudohypertrophic myopathy in cysticercosis. Neurology 1976;26:270-2.
7. SINGH G, SAWHNEY IS. Taenia solium cysticercosis: uncommon manifestations. In: Singh G, Prabhakar S, eds. Taenia solium cysticercosis: from basic to clinical science. Oxford, UK: CAB International, 2002;229-39.
8. ESCOBAR A, WEIDENHEIM KM. The pathology of neurocysticercosis. In: Singh G, Prabhakar S, eds. Taenia solium cysticercosis: from basic to clinical science. Oxford, UK: CAB International, 2002;289-305.
9. DIXON H, LIPSCOMB F. Cysticercosis: an analysis and follow up of 450 cases. Medical Resource Council Special Report no. 229. Her Majesty's Stationary Office, London, 1961.
10. ESCOBEDA F. Neurosurgical aspect of neurocysticercosis. In: Schmidek HH, Sweet WH, eds. Operative neurosurgical techniques: indications, methods and results. Orlando: Grune, Stratton, 1988;93-102.
11. DEL BRUTTO OH, SOTELO J. Neurocysticercosis: an update. Rev Infec Dis 1988;10:1075-87.
12. PATEL R, JHA S, YADAV RK. Pleomorphism of the clinical manifestations of neurocysticercosis. Trans R Soc Trop Med Hyg 2006;100:134-41.
13. NOBOA CA. Encefalitis cisticercosa. Rev Ecuat Neurol 1992;1:61-71.
14. CARPIO A, ESCOBAR A, HAUSER WA. Cysticercosis and epilepsy: a critical review. Epilepsia 1998;10:1025-40.
15. SINGH G, SINGH I, RANI A, KAUSHAL S, Avasthi. Epidemiologic classification of seizures associated with neurocysticercosis: observations from a sample of seizure disorders in neurologic care in India. Acta Neurol Scand 2006;113:233-40.
16. DEL BRUTTO OH, RAJSHEKHAR V, WHITE AC JR, WHITE AC JR, TSANG VC, NASH TE et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001;57:177-83.
17. GARCIA HH, PRETELL EJ, GILMAN RH, MARTINEZ SM, MOULTON LH, DEL BRUTTO OH et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004;350:249-58.
18. BERGSNEIDER M, HOLLY LT, LEE JH et al. Endoscopic management of cysticercal cysts within the lateral and third ventricles. J Neurosurg 2000;92:14-23.
19. ESTAÑOL B, KLERIGA E, LOYO M et al. Mechanisms of hydrocephalus in cerebral cysticercosis: implications for therapy. Neurosurgery 1983;13:119-23.
20. GROGL M, ESTRADA JJ, MACDONALD G, KUHN RE. Antigen-antibody analysis in neurocysticercosis. J Parasitol 1985;71:433-42.
21. SCHANTZ PM. Improvements in the serodiagnosis of helminthic zoonoses. Vet Parasitol 1987;25:95-120.
22. TSANG VC, BRAND JA, BOYER AE. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 1989;159:50-9.
23. WILSON M, BRYAN RT, FRIED JA et al. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 1991;164:1007-9.
24. BITTENCOURT PRM, GRACIA CM, GORZ AM et al. High-dose praziquantel for neurocysticercosis: efficacy and tolerability. Eur Neurol 1990;30:229-34.
25. DEL BRUTTO OH, CAMPOS X, SÁ NCHEZ J, MOSQUERA A. Single-day praziquantel versus 1-week albendazole for neurocysticercosis. Neurology 1999;52:1079-81.
26. GARCIA HH, DEL BRUTTO OH, NASH TE et al. New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg 2005;72:3-9.
27. GHIKA J, GHIKA-SCHMID F, B OGOUSSLASVKY J. Parietal motor syndrome: a clinical description in 32 patients in the acute phase of pure parietal strokes studied prospectively. Clin Neurol Neurosurg 1998;100:271-82.